272. Cost-Effectiveness of Sacubitril-Valsartan in Patients With Heart Failure With Reduced Ejection Fraction.
作者: Alexander T Sandhu.;Daniel A Ollendorf.;Richard H Chapman.;Steven D Pearson.;Paul A Heidenreich.
来源: Ann Intern Med. 2016年165卷10期681-689页
Sacubitril-valsartan therapy reduces cardiovascular mortality compared with enalapril therapy in patients with heart failure with reduced ejection fraction.
274. Tailoring Breast Cancer Screening Intervals by Breast Density and Risk for Women Aged 50 Years or Older: Collaborative Modeling of Screening Outcomes.
作者: Amy Trentham-Dietz.;Karla Kerlikowske.;Natasha K Stout.;Diana L Miglioretti.;Clyde B Schechter.;Mehmet Ali Ergun.;Jeroen J van den Broek.;Oguzhan Alagoz.;Brian L Sprague.;Nicolien T van Ravesteyn.;Aimee M Near.;Ronald E Gangnon.;John M Hampton.;Young Chandler.;Harry J de Koning.;Jeanne S Mandelblatt.;Anna N A Tosteson.; .
来源: Ann Intern Med. 2016年165卷10期700-712页
Biennial screening is generally recommended for average-risk women aged 50 to 74 years, but tailored screening may provide greater benefits.
|